Abstract
To understand the involvement of the systemic and cardiac components of the renin–angiotensin system (RAS) in the development of cardiac hypertrophy induced by salt intake, the present study analyzed the effect of high dietary salt (8.0% NaCl) in mice possessing a full complement (+/+) or ablation (−/−) of atrial natriuretic peptide (ANP). A 3 week treatment of 8.0% NaCl was able to induce cardiac hypertrophy in both genotypes, though exaggerated hypertrophy was noted in the ANP −/− mouse. Although a marked decrease in angiotensin II (Ang II) plasma levels in both genotypes fed a high salt diet was observed, systemic RAS mRNA components were altered only in the ANP −/− animals and remained unchanged in ANP +/+ mice. Decreased Ang II plasma levels were better correlated with decreases in angiotensinogen protein expression observed in both genotypes. High salt had no effect on cardiac RAS mRNA components in the ANP −/− animals, but did cause a significant decrease in some cardiac RAS mRNA components in ANP +/+ mice. As expected, high salt was able to increase plasma ANP levels and ventricular mRNA expression of ANP (ANP +/+ mice only) and B-type NP in both genotypes. The latter peptides are key cardiac markers of hypertrophy whose increased expression correlate well with the physical salt-induced cardiac alterations observed in this study. These findings suggest that although the RAS does not play a key role in salt-induced cardiac hypertrophy, ANP is an important determinant of the degree of salt-sensitivity observed in the proANP gene-disrupted animal. (Mol Cell Biochem 276: 121–131, 2005)
Similar content being viewed by others
References
Mizelle HL, Hall JE, Hildebrandt DA: Atrial natriuretic peptide and pressure natriuresis: interactions with the renin–angiotensin system. Am J Physiol 257: R1169–R1174, 1989
Johnston CI, Hodsman PG, Kohzuki M, Casley DJ, Fabris B, Phillips PA: Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists. Am J Med 87: 24S–28S, 1989
Johnston CI, Phillips PA, Arnolda L, Mooser V: Modulation of the renin–angiotensin system by atrial natriuretic peptide. J Cardiovasc Pharmacol 16(Suppl 7): S43–S46, 1990
Schmieder RE, Messerli FH, Garavaglia GE, Nunez BD: Dietary salt intake. A determinant of cardiac involvement in essential hypertension. Circulation 78: 951–956, 1988
Melo LG, Veress AT, Chong CK, Pang SC, Flynn TG, Sonnenberg H: Salt-sensitive hypertension in ANP knockout mice: potential role of abnormal plasma renin activity. Am J Physiol 274: R255–R261, 1998
Melo LG, Veress AT, Chong CK, Ackermann U, Sonnenberg H: Salt-sensitive hypertension in ANP knockout mice is prevented by AT1 receptor antagonist losartan. Am J Physiol 277: R624–R630, 1999
Griendling KK, Murphy TJ, Alexander RW: Molecular biology of the renin–angiotensin system. Circulation 87: 1816–1828, 1993
Dzau VJ: Molecular biology of angiotensin II biosynthesis and receptors. Can J Cardiol 11(Suppl F): 21F–26F, 1995
Dinh DT, Frauman AG, Johnston CI, Fabiani ME: Angiotensin receptors: distribution, signalling and function. Clin Sci (Lond) 100: 481–492, 2001
Stroth U, Unger T: The renin–angiotensin system and its receptors. J Cardiovasc Pharmacol 33(Suppl 1): S21–S28, 1999
Sakata Y, Masuyama T, Yamamoto K, Doi R, Mano T, Kuzuya T, et~al.: Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy. J Am Coll Cardiol 37: 293–299, 2001
Levin ER, Gardner DG, Samson WK: Natriuretic peptides. N Engl J Med 339: 321–328, 1998
John SW, Krege JH, Oliver PM, Hagaman JR, Hodgin JB, Pang SC, et~al.: Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267: 679–681, 1995
Sun JZ, Chen SJ, Majid-Hasan E, Oparil S, Chen YF: Dietary salt supplementation selectively downregulates NPR-C receptor expression in kidney independently of ANP. Am J Physiol Renal Physiol 282: F220–F227, 2002
Tse MY, Watson JD, Sarda IR, Flynn TG, Pang SC: Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol Cell Biochem 219: 99–105, 2001
Sangaralingham SJ, Pak BJ, Tse MY, Angelis E, Adams MA, Smallegange C, et~al.: Expression of the translational repressor NAT1 in experimental models of cardiac hypertrophy. Mol Cell Biochem 245: 183–190, 2003
Zhao X, White R, Van Huysse J, Leenen FH: Cardiac hypertrophy and cardiac renin–angiotensin system in Dahl rats on high salt intake. J Hypertens 18: 1319–1326, 2000
Lal A, Veinot JP, Leenen FH: Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone. Am J Hypertens 16: 319–323, 2003
Yuan BX, Leenen FH: Dietary sodium intake and left ventricular hypertrophy in normotensive rats. Am J Physiol 261: H1397–H1401, 1991
Feng JA, Perry G, Mori T, Hayashi T, Oparil S, Chen YF: Pressure-independent enhancement of cardiac hypertrophy in atrial natriuretic peptide-deficient mice. Clin Exp Pharmacol Physiol 30: 343–349, 2003
Tamura K, Umemura S, Fukamizu A, Ishii M, Murakami K: Recent advances in the study of renin and angiotensinogen genes: from molecules to the whole body. Hypertens Res 18: 7–18, 1995
Harmsen E, Leenen FH: Dietary sodium induced cardiac hypertrophy. Can J Physiol Pharmacol 70: 580–586, 1992
Danser AH: Local renin–angiotensin systems: the unanswered questions. Int J Biochem Cell Biol 35: 759–768, 2003
Mazzolai L, Nussberger J, Aubert JF, Brunner DB, Gabbiani G, Brunner HR, et~al.: Blood pressure-independent cardiac hypertrophy induced by locally activated renin–angiotensin system. Hypertension 31: 1324–1330, 1998
Dostal DE, Baker KM: The cardiac renin–angiotensin system: conceptual, or a regulator of cardiac function? Circ Res 85: 643–650, 1999
Leenen FH, White R, Yuan B: Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin–angiotensin system. Am J Physiol Heart Circ Physiol 281: H2410–H2416, 2001
Wang D, Oparil S, Feng JA, Li P, Perry G, Chen LB, et~al.: Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension 42: 88–95, 2003
Gardner DG: Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol Metab 14: 411–416, 2003
Espiner EA: Physiology of natriuretic peptides. J Intern Med 235: 527–541, 1994
Rubattu S, Volpe M: The atrial natriuretic peptide: a changing view. J Hypertens 19: 1923–1931, 2001
Tamura N, Ogawa Y, Chusho H, Nakamura K, Nakao K, Suda M, et~al.: Cardiac fibrosis in mice lacking brain natriuretic peptide. Proc Natl Acad Sci USA 97: 4239–4244, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Angelis, E., Tse, M.Y. & Pang, S.C. Interactions between atrial natriuretic peptide and the renin–angiotensin system during salt-sensitivity exhibited by the proANP gene-disrupted mouse. Mol Cell Biochem 276, 121–131 (2005). https://doi.org/10.1007/s11010-005-3672-1
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11010-005-3672-1